JHP Pharmaceuticals L.L.C. is pleased to
announce the acquisition of Dantrium®
(dantrolene sodium) effective August 20th
2008. JHP is an integrated specialty
healthcare company that specializes in
sterile injectable products. JHP
manufactures and sells brand aseptic
injectable pharmaceuticals in hospital and
clinic settings, while providing contract
manufacturing services for global
pharmaceutical companies. JHP's own product
portfolio includes leading diagnostic,
women's health and anesthesia products.
Dantrium® (dantrolene sodium) fits our
objective of expanding our specialty
products portfolio to satisfy patients’ and
healthcare professionals’ needs.
We would like to thank you for being a loyal
customer of the Dantrium® brand and look
forward to working with you. Our goal is to
continue to provide you, our valued
customers, product supply without
interruption.
On behalf of JHP we extend our thanks for
your cooperation as we introduce Dantrium®
(dantrolene sodium) to our product line, and
we would like to thank you in advance for
your orders. We welcome you to continue to
navigate through our website at
www.jhppharma.com
to view other products we offer in
anesthesiology and other therapeutic areas.
Dantrium®
(dantrolene sodium)
